Probiotics as a Weapon in the Fight Against COVID-19.
作者信息
Stavropoulou Elisavet, Bezirtzoglou Eugenia
机构信息
Department of Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Service of Infectious Diseases, Central Institute of Valais Hospitals, Sion, Switzerland.
出版信息
Front Nutr. 2020 Dec 15;7:614986. doi: 10.3389/fnut.2020.614986. eCollection 2020.
Abstract
摘要
相似文献
1
Probiotics as a Weapon in the Fight Against COVID-19.
Front Nutr. 2020 Dec 15;7:614986. doi: 10.3389/fnut.2020.614986. eCollection 2020.
2
[Hygiene as a weapon in the fight against SARS-Cov-2. All experts in taking care!].
Soins. 2020 Oct;65(849):32-37. doi: 10.1016/S0038-0814(20)30241-3.
3
Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4062-4063. doi: 10.26355/eurrev_202004_20977.
4
Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
mBio. 2020 Oct 20;11(5):e02431-20. doi: 10.1128/mBio.02431-20.
5
Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Endocr Pract. 2020 Oct;26(10):1186-1195. doi: 10.4158/EP-2020-0336.
6
[Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver.
Exp Ther Med. 2020 Jul;20(1):147-150. doi: 10.3892/etm.2020.8692. Epub 2020 Apr 28.
7
Weapon-carrying, physical fighting, and fight-related injury among U.S. adolescents.
Am J Prev Med. 1998 Feb;14(2):122-9. doi: 10.1016/s0749-3797(97)00020-2.
8
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Transfusion. 2021 Feb;61(2):356-360. doi: 10.1111/trf.16161. Epub 2020 Oct 26.
9
Pathogenesis-directed therapy of 2019 novel coronavirus disease.
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
10
A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
Curr Pharm Des. 2021;27(3):423-439. doi: 10.2174/1381612826666200720233947.
引用本文的文献
1
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.
Front Microbiol. 2024 Dec 24;15:1500890. doi: 10.3389/fmicb.2024.1500890. eCollection 2024.
2
In Vitro Screening of Bacterial Isolates From Dairy Products for Probiotic Properties and Other Health-Promoting Attributes.
Food Sci Nutr. 2024 Nov 25;12(12):10756-10769. doi: 10.1002/fsn3.4537. eCollection 2024 Dec.
3
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support.
Viruses. 2024 Feb 27;16(3):370. doi: 10.3390/v16030370.
4
COVID-19 severity is associated with population-level gut microbiome variations.
Front Cell Infect Microbiol. 2022 Aug 23;12:963338. doi: 10.3389/fcimb.2022.963338. eCollection 2022.
5
Modulatory Impacts of Multi-Strain Probiotics on Rabbits' Growth, Nutrient Transporters, Tight Junctions and Immune System to Fight against Infection.
Animals (Basel). 2022 Aug 15;12(16):2082. doi: 10.3390/ani12162082.
6
Immunomodulatory Efficacy-Mediated Anti-HCV and Anti-HBV Potential of Kefir Grains; Unveiling the In Vitro Antibacterial, Antifungal, and Wound Healing Activities.
Molecules. 2022 Mar 21;27(6):2016. doi: 10.3390/molecules27062016.
7
Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19.
Mol Biol Rep. 2022 Jun;49(6):5153-5163. doi: 10.1007/s11033-022-07226-2. Epub 2022 Feb 15.
8
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review.
Trends Food Sci Technol. 2022 Feb;120:174-192. doi: 10.1016/j.tifs.2021.12.033. Epub 2022 Jan 2.
9
Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.
Phys Act Nutr. 2021 Jun;25(2):1-7. doi: 10.20463/pan.2021.0008. Epub 2021 Jun 30.
10
Probiotics as Adjunctive Treatment for Patients Contracted COVID-19: Current Understanding and Future Needs.
Front Nutr. 2021 Jun 10;8:669808. doi: 10.3389/fnut.2021.669808. eCollection 2021.
本文引用的文献
1
Probiotics in Medicine: A Long Debate.
Front Immunol. 2020 Sep 25;11:2192. doi: 10.3389/fimmu.2020.02192. eCollection 2020.
2
Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic.
Front Public Health. 2020 May 8;8:186. doi: 10.3389/fpubh.2020.00186. eCollection 2020.
3
Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach.
Biomed Res Int. 2020 May 11;2020:2683286. doi: 10.1155/2020/2683286. eCollection 2020.
4
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
5
Properties of Coronavirus and SARS-CoV-2.
Malays J Pathol. 2020 Apr;42(1):3-11.
6
Probiotics and COVID-19: one size does not fit all.
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):644-645. doi: 10.1016/S2468-1253(20)30122-9. Epub 2020 Apr 25.
7
Viroporins and inflammasomes: A key to understand virus-induced inflammation.
Int J Biochem Cell Biol. 2020 May;122:105738. doi: 10.1016/j.biocel.2020.105738. Epub 2020 Mar 7.
8
Immunotherapy in sepsis - brake or accelerate?
Pharmacol Ther. 2020 Apr;208:107476. doi: 10.1016/j.pharmthera.2020.107476. Epub 2020 Jan 10.
9
Coronavirus envelope protein: current knowledge.
Virol J. 2019 May 27;16(1):69. doi: 10.1186/s12985-019-1182-0.
10
Structural and functional characterization of the PDZ domain of the human phosphatase PTPN3 and its interaction with the human papillomavirus E6 oncoprotein.
Sci Rep. 2019 May 15;9(1):7438. doi: 10.1038/s41598-019-43932-x.
Zotero 插件